IT’S a chilly morning and you’ve just set off for work, when your brisk pace is suddenly stilled by an unbearable itch.

Yasmien Kurdi revealed that her daughter, Ayesha Zara, experienced bullying at school beginning in 2022. Ayesha's anxiety ...

Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, has filed an IPO to raise additional ...

The practice of surrogacy can be said to date back to the Bible; in Genesis 16, Abram is promised descendants by God, but his ...

Celltrion will promote Omlyclo at the World Allergy Congress in Kyoto this week ahead of the allergy drug's launch in Japan.

Take 1-2 teaspoons of powder mixed with 150ml of warm water, drink about 30 minutes before main meals. Maintain 1-2 times a ...

AbbVie today announced new findings from the Phase 3 AFFIRM study evaluating a new option for induction treatment with SKYRIZI® (risankizumab-rzaa) in adults with moderately to severely active Crohn's ...

Paradigm Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on transforming care for rare diseases, today announced it has been named a finalist for the 2026 Prix Galien USA "Best ...

Enanta Pharmaceuticals, Inc. announced that data for zelicapavir, its oral, once-daily, N-protein inhibitor in development for the treatment of respiratory syncytial virus (RSV), will be presented at ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, today announced ...

New prespecified analyses showed consistent findings across clinically important and difficult to treat subgroups, including patients with prior biologic exposure ...